195 related articles for article (PubMed ID: 37736725)
1. Association of metabolic syndrome and its components with the risk of urologic cancers: a prospective cohort study.
Jiang R; Wang X; Li Z; Cai H; Sun Z; Wu S; Chen S; Hu H
BMC Urol; 2023 Sep; 23(1):150. PubMed ID: 37736725
[TBL] [Abstract][Full Text] [Related]
2. Gout patients have an increased risk of developing most cancers, especially urological cancers.
Chen CJ; Yen JH; Chang SJ
Scand J Rheumatol; 2014; 43(5):385-90. PubMed ID: 24825466
[TBL] [Abstract][Full Text] [Related]
3. Global Burden of Urologic Cancers, 1990-2013.
Dy GW; Gore JL; Forouzanfar MH; Naghavi M; Fitzmaurice C
Eur Urol; 2017 Mar; 71(3):437-446. PubMed ID: 28029399
[TBL] [Abstract][Full Text] [Related]
4. Metabolic syndrome and risk of pancreatic cancer: A population-based prospective cohort study.
Xia B; He Q; Pan Y; Gao F; Liu A; Tang Y; Chong C; Teoh AYB; Li F; He Y; Zhang C; Yuan J
Int J Cancer; 2020 Dec; 147(12):3384-3393. PubMed ID: 32580250
[TBL] [Abstract][Full Text] [Related]
5. Associations of metabolic syndrome and C-reactive protein with mortality from total cancer, obesity-linked cancers and breast cancer among women in NHANES III.
Gathirua-Mwangi WG; Song Y; Monahan PO; Champion VL; Zollinger TW
Int J Cancer; 2018 Aug; 143(3):535-542. PubMed ID: 29488212
[TBL] [Abstract][Full Text] [Related]
6. An Updated Meta-analysis on the Risk of Urologic Cancer in Patients with Systemic Lupus Erythematosus.
Yeo J; Seo MS; Hwang IC; Shim JY
Arch Iran Med; 2020 Sep; 23(9):614-620. PubMed ID: 32979908
[TBL] [Abstract][Full Text] [Related]
7. Association between metabolic syndrome and its components and incident colorectal cancer in a prospective cohort study.
Tran TT; Gunathilake M; Lee J; Kim J
Cancer; 2022 Mar; 128(6):1230-1241. PubMed ID: 34762301
[TBL] [Abstract][Full Text] [Related]
8. Metabolic syndrome increases osteoarthritis risk: findings from the UK Biobank prospective cohort study.
Zhang S; Wang D; Zhao J; Zhao H; Xie P; Zheng L; Sheng P; Yuan J; Xia B; Wei F; Zhang Z
BMC Public Health; 2024 Jan; 24(1):233. PubMed ID: 38243159
[TBL] [Abstract][Full Text] [Related]
9. Association of metabolic syndrome and its components with the risk of kidney cancer: A cohort-based case-control study.
Jiang R; Li Z; Wang X; Cai H; Wu S; Chen S; Hu H
Technol Health Care; 2023; 31(4):1235-1244. PubMed ID: 36617800
[TBL] [Abstract][Full Text] [Related]
10. Metabolic syndrome biomarkers and prostate cancer risk in the UK Biobank.
Monroy-Iglesias MJ; Russell B; Crawley D; Allen NE; Travis RC; Perez-Cornago A; Van Hemelrijck M; Beckmann K
Int J Cancer; 2021 Feb; 148(4):825-834. PubMed ID: 33405276
[TBL] [Abstract][Full Text] [Related]
11. [Metabolic syndrome components and renal cell cancer risk in Chinese males: a population-based prospective study].
Li X; Li N; Wen Y; Lyu ZY; Feng XS; Wei LP; Chen YH; Chen HD; Wang G; Chen SH; Ren JS; Shi JF; Cui H; Wu SL; Dai M; He J
Zhonghua Yu Fang Yi Xue Za Zhi; 2020 Jun; 54(6):638-643. PubMed ID: 32842279
[No Abstract] [Full Text] [Related]
12. Coffee and tea drinking and risk of cancer of the urinary tract in male smokers.
Hashemian M; Sinha R; Murphy G; Weinstein SJ; Liao LM; Freedman ND; Abnet CC; Albanes D; Loftfield E
Ann Epidemiol; 2019 Jun; 34():33-39. PubMed ID: 31023511
[TBL] [Abstract][Full Text] [Related]
13. Metabolic syndrome and early stage breast cancer outcome: results from a prospective observational study.
Buono G; Crispo A; Giuliano M; De Angelis C; Schettini F; Forestieri V; Lauria R; De Laurentiis M; De Placido P; Rea CG; Pacilio C; Esposito E; Grimaldi M; Nocerino F; Porciello G; Giudice A; Amore A; Minopoli A; Botti G; De Placido S; Trivedi MV; Arpino G
Breast Cancer Res Treat; 2020 Jul; 182(2):401-409. PubMed ID: 32500397
[TBL] [Abstract][Full Text] [Related]
14. Association of metabolic syndrome and the risk of bladder cancer: A prospective cohort study.
Fang S; Liu Y; Dai H; Gao T; Zeng L; Sun R; Zheng Z; Yuan J; Xia B; Pan Y
Front Oncol; 2022; 12():996440. PubMed ID: 36263231
[TBL] [Abstract][Full Text] [Related]
15. Dissecting the association between metabolic syndrome and prostate cancer risk: analysis of a large clinical cohort.
Bhindi B; Locke J; Alibhai SMH; Kulkarni GS; Margel DS; Hamilton RJ; Finelli A; Trachtenberg J; Zlotta AR; Toi A; Hersey KM; Evans A; van der Kwast TH; Fleshner NE
Eur Urol; 2015 Jan; 67(1):64-70. PubMed ID: 24568896
[TBL] [Abstract][Full Text] [Related]
16. Association of spironolactone use with risk of urinary tract cancer in the general population: A matched population-based cohort study.
Chen LC; Yang HJ; Yu BH; Lee MS; Lin HY; Chiou WY; Liu DW; Hsu FC; Chew CH; Hung SK
PLoS One; 2024; 19(3):e0300391. PubMed ID: 38536840
[TBL] [Abstract][Full Text] [Related]
17. Urologic cancer in Thailand.
Lojanapiwat B
Jpn J Clin Oncol; 2015 Nov; 45(11):1007-15. PubMed ID: 26355159
[TBL] [Abstract][Full Text] [Related]
18. Metabolic Syndrome Is Associated With an Increased Risk of Rheumatoid Arthritis: A Prospective Cohort Study Including 369,065 Participants.
Luo P; Xu W; Ye D; Chen W; Ying J; Liu B; Li J; Sun X; He Z; Wen C; Mao Y
J Rheumatol; 2024 Apr; 51(4):360-367. PubMed ID: 38224984
[TBL] [Abstract][Full Text] [Related]
19. Patients with periodontitis might increase the risk of urologic cancers: a bidirectional two-sample Mendelian randomization study.
Li B; Lin Y; Yang Y; Wang Z; Shi R; Zheng T; Liao B; Liao G; Huang J
Int Urol Nephrol; 2024 Apr; 56(4):1243-1251. PubMed ID: 38015384
[TBL] [Abstract][Full Text] [Related]
20. [De novo urologic tumors in kidney transplant patients].
Rodríguez Faba O; Breda A; Gausa L; Palou J; Villavicencio H
Actas Urol Esp; 2015 Mar; 39(2):122-7. PubMed ID: 24996779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
